West Pharmaceutical Services Inc
WST224.450USD
+2.539+1.14%
Cierre 06/16, 16:00（ET）Cotizaciones retrasadas 15 min
16.12BCap. mercado
32.71P/E TTM
Más Datos de West Pharmaceutical Services Inc Compañía
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Información de la empresa
Símbolo de cotizaciónWST
Nombre de la empresaWest Pharmaceutical Services Inc
Fecha de salida a bolsaJul 27, 1923
Fundada en1923
Director ejecutivoMr. Eric Mark Green
Número de empleados10600
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 27
Dirección530 Herman O. West Drive
CiudadEXTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal19341
Teléfono16105942900
Sitio Webhttps://www.westpharma.com/
Símbolo de cotizaciónWST
Fecha de salida a bolsaJul 27, 1923
Fundada en1923
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+11.41%
Mr. Bernard John Birkett
Mr. Bernard John Birkett
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
7.54K
+9.37%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+34.90%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+98.08%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de abr
Divisa: USDActualizado: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.23B
42.54%
Other European Countries
385.50M
13.32%
Germany
372.50M
12.88%
Other
339.00M
11.72%
Ireland
323.20M
11.17%
France
242.20M
8.37%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
High Value Components
1.30B
45.00%
Standard Packaging
636.50M
22.00%
Contract-Manufactured Products
549.71M
19.00%
Delivery Devices
405.05M
14.00%
Estadísticas de accionistas
Actualizado: dom., 18 de may
Actualizado: dom., 18 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.81%
BlackRock Institutional Trust Company, N.A.
5.77%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.46%
Walter Scott & Partners Ltd.
3.26%
Other
69.15%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.81%
BlackRock Institutional Trust Company, N.A.
5.77%
Brown Advisory
4.55%
State Street Global Advisors (US)
4.46%
Walter Scott & Partners Ltd.
3.26%
Other
69.15%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
45.38%
Investment Advisor
36.36%
Hedge Fund
5.93%
Pension Fund
3.55%
Research Firm
2.41%
Bank and Trust
1.67%
Sovereign Wealth Fund
1.32%
Insurance Company
0.72%
Endowment Fund
0.62%
Other
2.02%
Participación institucional
Actualizado: lun., 20 de ene
Actualizado: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1622
71.47M
99.46%
-1.08M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
2023Q1
1586
71.76M
96.63%
-2.52M
2022Q4
1564
71.37M
96.40%
-822.34K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
8.96M
12.39%
-463.00
-0.01%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
4.14M
5.72%
-38.26K
-0.92%
Dec 31, 2024
Brown Advisory
2.55M
3.53%
+266.49K
+11.66%
Dec 31, 2024
State Street Global Advisors (US)
3.25M
4.49%
+32.27K
+1.00%
Dec 31, 2024
Walter Scott & Partners Ltd.
2.42M
3.34%
+40.48K
+1.70%
Dec 31, 2024
Artisan Partners Limited Partnership
3.11M
4.3%
+44.38K
+1.45%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.78M
2.46%
+38.76K
+2.23%
Dec 31, 2024
APG Asset Management N.V.
1.44M
1.99%
-871.45K
-37.74%
Dec 31, 2024
Franklin Advisers, Inc.
1.75M
2.42%
-502.73K
-22.29%
Dec 31, 2024
Ver más
ETFs relacionados
Actualizado: vie., 6 de jun
Actualizado: vie., 6 de jun
Nombre
Proporción
Amplify Weight Loss Drug & Treatment ETF
4.06%
Motley Fool Mid-Cap Growth ETF
2.65%
VanEck Morningstar Wide Moat Growth ETF
2.6%
VanEck Morningstar Wide Moat ETF
2.09%
First Trust Indxx Medical Devices ETF
1.93%
American Century Mid Cap Growth Impact ETF
1.59%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Nuveen ESG Mid-Cap Growth ETF
1.57%
FT Vest S&P 500 Dividend Aristocrats Tgt Inc
1.4%
VanEck Morningstar Wide Moat Value ETF
1.37%
Ver más
Amplify Weight Loss Drug & Treatment ETF
Proporción4.06%
Motley Fool Mid-Cap Growth ETF
Proporción2.65%
VanEck Morningstar Wide Moat Growth ETF
Proporción2.6%
VanEck Morningstar Wide Moat ETF
Proporción2.09%
First Trust Indxx Medical Devices ETF
Proporción1.93%
American Century Mid Cap Growth Impact ETF
Proporción1.59%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.59%
Nuveen ESG Mid-Cap Growth ETF
Proporción1.57%
FT Vest S&P 500 Dividend Aristocrats Tgt Inc
Proporción1.4%
VanEck Morningstar Wide Moat Value ETF
Proporción1.37%
Dividendos
Un total de
269.40M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Mar 03, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on May 03, 2023 going ex on Apr 25, 2023
Apr 26, 2023
May 03, 2023
Apr 25, 2023
Dec 13, 2022
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Feb 01, 2023 going ex on Jan 24, 2023
Jan 25, 2023
Feb 01, 2023
Jan 24, 2023
Oct 27, 2022
WST.NB Final Cash Dividend of gross USD 0.19 paid on Nov 16, 2022 going ex on Nov 08, 2022
Nov 09, 2022
Nov 16, 2022
Nov 08, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
